JeanMarie Lisnock

Statistics

Publications

Citations

1.6K

H-Index

Active since

1998

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

JeanMarie Lisnock is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1998–2019

Publications

The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)

Margarita García‐Calvo, JeanMarie Lisnock, Herbert G. Bull et al. · Proceedings of the National Academy of Sciences · 2005 · 768 citations

Life Sciences, Molecular Biology, Pharmacology +14

Deficiency in Inducible Nitric Oxide Synthase Results in Reduced Atherosclerosis in Apolipoprotein E-Deficient Mice

Patricia A. Detmers, Melba Hernandez, John S. Mudgett et al. · The Journal of Immunology · 2000 · 209 citations · Full text

Life Sciences, Cardiology, Inflammation +12

The Structure of JNK3 in Complex with Small Molecule Inhibitors

Giovanna Scapin, Sangita B. Patel, JeanMarie Lisnock et al. · Chemistry & Biology · 2003 · 129 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +12

Molecular Basis for p38 Protein Kinase Inhibitor Specificity

JeanMarie Lisnock, Andy Tebben, Betsy Frantz et al. · Biochemistry · 1998 · 95 citations

Life Sciences, Molecular Biology, Pharmacology +13

From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9

Whitney L. Petrilli, Gregory C. Adam, Roman S. Erdmann et al. · Cell chemical biology · 2019 · 83 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +12

1–5 of 18